Home

The Korea Herald

Latest news

Most Popular

  1. 1

    $200m a year, 700,000 tons of rice, space tech: The deal for North Korea in joining Russia’s war

    $200m a year, 700,000 tons of rice, space tech: The deal for North Korea in joining Russia’s war
  2. 2

    Korean battery makers brace for impact of US election

    Korean battery makers brace for impact of US election
  3. 3

    Who is writer of Hybe's controversial internal report?

    Who is writer of Hybe's controversial internal report?
  4. 4

    [AtoZ of Korean mind] Ever noticed some Koreans talk to themselves?

    [AtoZ of Korean mind] Ever noticed some Koreans talk to themselves?
  5. 5

    Will South Korea go back to banning phones in classrooms?

    Will South Korea go back to banning phones in classrooms?
  1. 6

    After opposition U-turn, Korea to repeal plan for financial capital gains tax

    After opposition U-turn, Korea to repeal plan for financial capital gains tax
  2. 7

    Scandal-hit ex-lawmaker denies corruption claims as pressure on Yoon mounts

    Scandal-hit ex-lawmaker denies corruption claims as pressure on Yoon mounts
  3. 8

    Gangnam Station ramming suspect to face detention

    Gangnam Station ramming suspect to face detention
  4. 9

    [From the Scene] Gumi, home to Nongshim’s largest factory, rebrands itself as ‘city of ramyeon'

    [From the Scene] Gumi, home to Nongshim’s largest factory, rebrands itself as ‘city of ramyeon'
  5. 10

    Stray Kids' US album sales surpass 1M

    Stray Kids' US album sales surpass 1M
소아쌤

Govt. to lower age of eligibility for COVID-19 treatment pills from 65 to 60: PM

By Yonhap

Published : Jan. 21, 2022 - 09:30

    • Link copied

A pharmacist checks boxes containing Paxlovid, COVID-19 treatment pills developed by US pharmaceutical giant Pfizer Inc., at a drugstore in Seoul last Friday, as South Korea began to prescribe and administer COVID-19 treatment pills the same day, starting with patients with a weak immune system and those over the age of 65. (Yonhap) A pharmacist checks boxes containing Paxlovid, COVID-19 treatment pills developed by US pharmaceutical giant Pfizer Inc., at a drugstore in Seoul last Friday, as South Korea began to prescribe and administer COVID-19 treatment pills the same day, starting with patients with a weak immune system and those over the age of 65. (Yonhap)
The government will lower the age of eligibility for COVID-19 treatment pills from 65 to 60 to better contain the spread of the omicron variant, Prime Minister Kim Boo-kyum said Friday.

Kim announced the measure during a COVID-19 response meeting held a day after President Moon Jae-in said omicron has become the dominant strain in the country.

The first batch of Pfizer Inc.'s COVID-19 treatment pills arrived in the country last week to be administered first to those with compromised immune systems and those aged 65 and above. (Yonhap)

More from Headlines